Certain oncogenic lncRNAs modulate tumor immunogenicity within tumor cells by either suppressing tumor antigen production directly or enhancing the expression of immune checkpoints (e.g., PD-L1, IDO) and HLA-G indirectly. The gene discussed is CD274; the disease is neoplasm.